| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.88B | 47.54B | 46.07B | 43.14B | 39.37B | 19.78B |
| Gross Profit | 3.32B | 3.49B | 3.32B | 4.28B | 5.53B | 3.22B |
| EBITDA | 3.40B | 3.50B | 4.37B | 4.63B | 5.45B | 3.22B |
| Net Income | -63.08M | 20.13M | 860.81M | 1.86B | 2.61B | 1.65B |
Balance Sheet | ||||||
| Total Assets | 63.26B | 59.84B | 53.84B | 46.10B | 36.80B | 24.21B |
| Cash, Cash Equivalents and Short-Term Investments | 2.76B | 2.26B | 1.25B | 1.40B | 2.37B | 1.19B |
| Total Debt | 35.13B | 30.38B | 26.31B | 20.70B | 13.80B | 10.57B |
| Total Liabilities | 47.62B | 43.96B | 39.36B | 33.51B | 25.69B | 15.94B |
| Stockholders Equity | 12.57B | 12.76B | 12.90B | 12.11B | 10.98B | 8.13B |
Cash Flow | ||||||
| Free Cash Flow | 2.46B | -1.24B | 134.87M | -1.22B | 534.69M | -725.01M |
| Operating Cash Flow | 2.42B | 1.44B | 2.20B | 3.16B | 4.21B | 1.14B |
| Investing Cash Flow | -7.05B | -3.64B | -1.71B | -9.18B | -5.13B | -2.19B |
| Financing Cash Flow | 3.32B | 3.05B | -455.15M | 4.93B | 2.02B | 1.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | HK$4.08B | 7.18 | 9.36% | 6.97% | -3.73% | 6.09% | |
62 Neutral | HK$16.23B | 11.74 | 10.43% | 0.93% | -1.43% | 113.67% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | HK$1.21B | 16.88 | 3.61% | 1.85% | -8.51% | -68.34% | |
57 Neutral | HK$2.78B | 3.69 | 13.87% | ― | 9.20% | 213.87% | |
54 Neutral | HK$10.29B | -145.28 | -0.52% | 1.13% | -15.17% | -125.24% | |
54 Neutral | HK$1.22B | 18.94 | 2.46% | 3.73% | -5.29% | -32.47% |
China Risun Group Ltd. announced the disposal of its 100% equity interest in a subsidiary to Xuyang New Energy for RMB54,686,200. This transaction, classified as a connected transaction due to the involvement of the company’s controlling shareholder, does not require independent shareholders’ approval. The sale aligns with the company’s strategic adjustments, impacting its financial consolidation and potentially altering its market positioning.
The most recent analyst rating on (HK:1907) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Risun Group Ltd. stock, see the HK:1907 Stock Forecast page.
China Risun Group Limited has announced the termination of a framework agreement with Beijing SinoHytec regarding a potential disposal and capital increase. The decision was made due to the inability to reach a consensus on the definitive plan, but the company assures that this will not adversely affect its business operations or financial position. The group remains open to future strategic cooperation with Beijing SinoHytec.
The most recent analyst rating on (HK:1907) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Risun Group Ltd. stock, see the HK:1907 Stock Forecast page.
China Risun Group Limited has announced a change in the book closure period and record date for its interim dividend for the six months ended June 30, 2025. The new book closure period is from September 16 to September 18, 2025, with the record date now set for September 18, 2025. This adjustment allows shareholders to ensure their eligibility for the RMB0.20 per share dividend, with the payment date remaining unchanged at September 30, 2025.
The most recent analyst rating on (HK:1907) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Risun Group Ltd. stock, see the HK:1907 Stock Forecast page.
China Risun Group Ltd. announced a change in the book closure period and record date for its interim cash dividend for the financial year ending December 31, 2025. The dividend declared is RMB 0.002 per share, with the ex-dividend date set for September 12, 2025, and payment scheduled for September 30, 2025. This update may affect shareholders’ planning and the company’s financial operations, reflecting its commitment to providing returns to investors.
The most recent analyst rating on (HK:1907) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Risun Group Ltd. stock, see the HK:1907 Stock Forecast page.
China Risun Group Limited announced the grant of 9,915,000 share awards to 197 eligible participants, including directors and employees, under its Share Award Plan. The awarded shares, which are subject to performance targets and a vesting period of 60 months, aim to incentivize and retain key personnel. The grant reflects the company’s strategic focus on achieving revenue growth and operational efficiency, with a clawback mechanism in place to address any misconduct or financial misstatements.
The most recent analyst rating on (HK:1907) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Risun Group Ltd. stock, see the HK:1907 Stock Forecast page.
China Risun Group Limited reported its unaudited interim results for the six months ended June 30, 2025, showing mixed performance. While the production volumes of coke, refined chemicals, and high-purified hydrogen increased significantly, the company experienced a decline in revenue and profits by 18.5% and 34.9% respectively, year-on-year. Basic earnings per share also saw a substantial decrease of 74.0%. The board declared an interim dividend of RMB0.20 cents per share, a reduction from the previous period. These results indicate operational growth but financial challenges, impacting stakeholders and market positioning.
The most recent analyst rating on (HK:1907) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Risun Group Ltd. stock, see the HK:1907 Stock Forecast page.
China Risun Group Ltd. announced its unaudited interim results for the six months ending June 30, 2025, declaring an interim cash dividend of RMB 0.002 per share. This announcement reflects the company’s ongoing financial strategies and its commitment to providing returns to its shareholders, potentially impacting its market positioning and stakeholder confidence.
The most recent analyst rating on (HK:1907) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Risun Group Ltd. stock, see the HK:1907 Stock Forecast page.
China Risun Group Limited has announced that its Board of Directors will convene on August 29, 2025, to review and approve the interim financial results for the first half of the year ending June 30, 2025. The meeting will also consider the declaration of an interim dividend, which could impact the company’s financial strategies and shareholder returns.